Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan-based 7-day triple therapy vs Omeprazole-based 14-day triple therapy for Helicobacter pylori infection
TCTR20210219007Phase 4Enrolling by invitation
- Sponsor
- Rajavithi Hospital Research Department
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan, omeprazole in Helicobacter pylori infection, sponsored by Rajavithi Hospital Research Department. Started Nov 2019; status: enrolling by invitation.
02
Drugs
vonoprazanomeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on TCTR20210219007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210219007.